Literature DB >> 6389373

Immunohistological evidence, obtained with monoclonal antibodies, of small intestinal brush border hydrolases in human colon cancers and foetal colons.

A Zweibaum, H P Hauri, E Sterchi, I Chantret, K Haffen, J Bamat, B Sordat.   

Abstract

The expression of small intestinal hydrolases associated with the enterocyte brush border membrane was studied in human colon cancers and foetal colons, by means of monoclonal antibodies against human small intestinal sucrase-isomaltase (SI), maltase-glucoamylase (MGA), lactase (L), aminopeptidase N (APN), and dipeptidylpeptidase IV (DPP-IV). The enzymes were visualized by indirect immunofluorescence on cryostat sections of tumors developed in nude mice with 6 human colon carcinoma cell lines (HT-29, Caco-2, SW-480, HRT-18, HCT-8R, and Co-115), of 27 primary colorectal carcinomas from patients, and of human foetal (16 to 20 weeks of gestation) and normal adult small intestines and colons. All 5 monoclonals bound to the brush border of the adult small intestine, but not to that of the adult colon mucosa. Antibodies against SI, APN and DPP-IV also bound to the brush border of the foetal colons, to apical borders in HT-29 and Caco-2 tumors in nude mice, and to brush border-like structures in 7/27 tumors from patients. No binding was observed for MGA and L in either tumors or foetal colons. Binding of anti-SI antibodies to the brush border of the juxta-tumoral mucosal epithelium was observed in 9/11 samples tested. These data indicate that some colon tumors exhibit a typical pattern of enterocytic differentiation which is of foetal type and which involves at least 3 brush border membrane hydrolases. Monoclonal antibodies to small intestinal hydrolases may, therefore, be important tools for identification and characterization of some differentiated colonic tumors.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6389373     DOI: 10.1002/ijc.2910340502

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  28 in total

1.  Caco-2 cell monolayers as a model for drug transport across the intestinal mucosa.

Authors:  A R Hilgers; R A Conradi; P S Burton
Journal:  Pharm Res       Date:  1990-09       Impact factor: 4.200

2.  Hsp70 negatively controls rotavirus protein bioavailability in caco-2 cells infected by the rotavirus RF strain.

Authors:  Alexis H Broquet; Christelle Lenoir; Agnès Gardet; Catherine Sapin; Serge Chwetzoff; Anne-Marie Jouniaux; Susana Lopez; Germain Trugnan; Maria Bachelet; Ginette Thomas
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

3.  Two HNF-1 binding sites govern the glucose repression of the human sucrase-isomaltase promoter.

Authors:  A Rodolosse; V Carriere; M Rousset; M Lacasa
Journal:  Biochem J       Date:  1998-11-15       Impact factor: 3.857

Review 4.  Ontogeny, growth and development of the small intestine: Understanding pediatric gastroenterology.

Authors:  Laurie A Drozdowski; Tom Clandinin; Alan B R Thomson
Journal:  World J Gastroenterol       Date:  2010-02-21       Impact factor: 5.742

5.  Regulation of the gene for human dipeptidyl peptidase IV by hepatocyte nuclear factor 1 alpha.

Authors:  R H Erickson; J R Gum; C D Lotterman; J W Hicks; R S Lai; Y S Kim
Journal:  Biochem J       Date:  1999-02-15       Impact factor: 3.857

6.  Early biochemical responses of the small intestine of coeliac patients to wheat gluten.

Authors:  D S Bailey; A R Freedman; S C Price; D Chescoe; P J Ciclitira
Journal:  Gut       Date:  1989-01       Impact factor: 23.059

7.  Accumulation and oriented transport of ampicillin in Caco-2 cells from its pivaloyloxymethylester prodrug, pivampicillin.

Authors:  Hugues Chanteux; Françoise Van Bambeke; Marie-Paule Mingeot-Leclercq; Paul M Tulkens
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

8.  Interplay between CYP3A-mediated metabolism and polarized efflux of terfenadine and its metabolites in intestinal epithelial Caco-2 (TC7) cell monolayers.

Authors:  S D Raeissi; I J Hidalgo; J Segura-Aguilar; P Artursson
Journal:  Pharm Res       Date:  1999-05       Impact factor: 4.200

9.  Peptide YY selectively stimulates expression of the colonocytic phenotype.

Authors:  S A Sgambati; G A Turowski; M D Basson
Journal:  J Gastrointest Surg       Date:  1997 Nov-Dec       Impact factor: 3.452

10.  Clonal analysis of sucrase-isomaltase expression in the human colon adenocarcinoma Caco-2 cells.

Authors:  J F Beaulieu; A Quaroni
Journal:  Biochem J       Date:  1991-12-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.